Analysis | Metabolite Name | Measured Value | Units | Feeding | Group |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 1340 | Peak area | Fed | LCR-AL |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 1700 | Peak area | Fed | LCR-CR |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 1904 | Peak area | Fed | LCR-CR |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 2499 | Peak area | Fast | LCR-AL |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 2522 | Peak area | Fed | HCR-AL |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 2671 | Peak area | Fed | LCR-AL |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 2672 | Peak area | Fast | HCR-AL |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 2780 | Peak area | Fast | HCR-AL |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 2948 | Peak area | Fed | LCR-AL |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 3050 | Peak area | Fed | LCR-AL |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 3673 | Peak area | Fast | LCR-AL |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | 8988 | Peak area | Fed | LCR-AL |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | Peak area | Fast | HCR-AL | |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | Peak area | Fast | HCR-CR | |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | Peak area | Fast | LCR-AL | |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | Peak area | Fast | LCR-CR | |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | Peak area | Fed | HCR-AL | |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | Peak area | Fed | HCR-CR | |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | Peak area | Fed | LCR-AL | |
Reversed phase NEGATIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M-H)- | Peak area | Fed | LCR-CR | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 2022 | Peak area | Fed | HCR-CR |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 5281 | Peak area | Fast | LCR-CR |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 7990 | Peak area | Fed | LCR-AL |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 9344 | Peak area | Fed | HCR-AL |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 12050 | Peak area | Fed | LCR-AL |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | 17851 | Peak area | Fed | LCR-AL |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Fast | HCR-AL | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Fast | HCR-CR | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Fast | LCR-AL | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Fast | LCR-CR | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Fed | HCR-AL | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Fed | HCR-CR | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Fed | LCR-AL | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETATE (CAS# 156-38-7); (M+H)+ | Peak area | Fed | LCR-CR |